THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / COM
Total 13F shares
157,569,577
Share change
+5,159,987
Total reported value
$249,322,171
Put/Call ratio
105%
Price per share
$1.58
Number of holders
139
Value change
+$8,915,683
Number of buys
43
Number of sells
68

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q3 2020

As of 30 Sep 2020, THERAPEUTICSMD INC - COM (TXMD) was held by 139 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 157,569,577 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., FMR LLC, Rubric Capital Management LP, JPMORGAN CHASE & CO, VANGUARD GROUP INC, C WorldWide Group Holding A/S, GMT CAPITAL CORP, STATE STREET CORP, and SANDERS MORRIS HARRIS LLC. This page lists 139 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.